Levitronix Continues Testing On Recalled CentriMag Blood Pumping System
This article was originally published in The Gray Sheet
Executive Summary
With the help of FDA, Zurich-based Levitronix continues testing to better understand the root cause of two adverse events that led to a Class I recall of its CentriMag extracorporeal blood pumping system, along with the CentriMag primary and back-up consoles